These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 15007880

  • 1. [Clinical efficacy of oral clarithromycin monotherapy in patients with mild or moderate community-acquired pneumonia].
    Fujiki R, Rikimaru T, Aizawa H, Kawayama T.
    Jpn J Antibiot; 2003 Dec; 56(6):712-8. PubMed ID: 15007880
    [Abstract] [Full Text] [Related]

  • 2. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G, Niederman MS, Nusrat R, Patel M, Lavin B.
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [Abstract] [Full Text] [Related]

  • 3. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Community Acquired Pneumonia Study Group.
    Patel T, Pearl J, Williams J, Haverstock D, Church D.
    Respir Med; 2000 Feb; 94(2):97-105. PubMed ID: 10714413
    [Abstract] [Full Text] [Related]

  • 5. The incidence and etiology of community-acquired pneumonia in fever outpatients.
    Bao Z, Yuan X, Wang L, Sun Y, Dong X.
    Exp Biol Med (Maywood); 2012 Nov; 237(11):1256-61. PubMed ID: 23239436
    [Abstract] [Full Text] [Related]

  • 6. The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
    Soepandi P, Mangunnegoro H, Yunus F, Gunawan J.
    Respirology; 1998 Jun; 3(2):113-7. PubMed ID: 9692520
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial selection for community-acquired lower respiratory tract infections in the 21st century: a review of gemifloxacin.
    Appelbaum PC, Gillespie SH, Burley CJ, Tillotson GS.
    Int J Antimicrob Agents; 2004 Jun; 23(6):533-46. PubMed ID: 15194123
    [Abstract] [Full Text] [Related]

  • 8. [A multicentre study on the pathogenic agents in 665 adult patients with community-acquired pneumonia in cities of China].
    Liu YN, Chen MJ, Zhao TM, Wang H, Wang R, Liu QF, Cai BQ, Cao B, Sun TY, Hu YJ, Xiu QY, Zhou X, Ding X, Yang L, Zhuo JS, Tang YC, Zhang KX, Liang DR, Lü XJ, Li SQ, Liu Y, Yu YS, Wei ZQ, Ying KJ, Zhao F, Chen P, Hou XN.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):3-8. PubMed ID: 16638292
    [Abstract] [Full Text] [Related]

  • 9. [Clinical efficacy of clarithromycin delayed release dosage form in the treatment of community-acquired pneumonia].
    Iutanova NS.
    Antibiot Khimioter; 2004 Jan; 49(3):17-21. PubMed ID: 15344392
    [Abstract] [Full Text] [Related]

  • 10. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.
    Kohno S, Tateda K, Kadota J, Fujita J, Niki Y, Watanabe A, Nagashima M.
    J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328
    [Abstract] [Full Text] [Related]

  • 11. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
    Jones RN, Sader HS, Stilwell MG, Fritsche TR.
    Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
    [Abstract] [Full Text] [Related]

  • 12. Nationwide, multicenter survey on the efficacy and safety of piperacillin for adult community-acquired pneumonia in Japan.
    Yamamoto Y, Watanabe A, Goto H, Matsushima T, Abe S, Aoki N, Shimokata K, Mikasa K, Niki Y, Kohno S.
    J Infect Chemother; 2012 Aug; 18(4):544-51. PubMed ID: 22618270
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Culture versus polymerase chain reaction for the etiologic diagnosis of community-acquired pneumonia in antibiotic-pretreated pediatric patients.
    Deng J, Zheng Y, Zhao R, Wright PF, Stratton CW, Tang YW.
    Pediatr Infect Dis J; 2009 Jan; 28(1):53-5. PubMed ID: 19034066
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epidemiology, clinical characteristics and antimicrobial resistance patterns of community-acquired pneumonia in 1702 hospitalized children in Singapore.
    Chiang WC, Teoh OH, Chong CY, Goh A, Tang JP, Chay OM.
    Respirology; 2007 Mar; 12(2):254-61. PubMed ID: 17298459
    [Abstract] [Full Text] [Related]

  • 18. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
    Iroezindu MO, Chima EI, Isiguzo GC, Mbata GC, Onyedum CC, Onyedibe KI, Okoli LE.
    Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
    [Abstract] [Full Text] [Related]

  • 19. Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point.
    File TM, Eckburg PB, Talbot GH, Llorens L, Friedland HD.
    Int J Antimicrob Agents; 2017 Aug; 50(2):247-251. PubMed ID: 28599867
    [Abstract] [Full Text] [Related]

  • 20. Activity of a novel series of acylides active against community-acquired respiratory pathogens.
    Pandya M, Chakrabarti A, Rathy S, Katoch R, Venkataraman R, Bhateja P, Mathur T, Kumar GR, Malhotra S, Rao M, Bhadauria T, Barman TK, Das B, Upadhyay D, Bhatnagar PK.
    Int J Antimicrob Agents; 2010 Aug; 36(2):169-74. PubMed ID: 20493666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.